Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe

This is a free web portal for the life sciences in German-speaking Europe... » read more

T-Knife GmbH Appoints CEO and CBO/CFO (2021-01-19)
T-knife GmbH, a next-generation adoptive T-cell therapy company leveraging its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, today announced the appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis ...
LignoPure: € 2.2m Seed Round from HTGF, IFH & Tanovis AG (2021-01-18)
LignoPure invented a unique approach to replace plastics through utilization of wood waste and the team just closed its seed round with HTGF, IFH and Tanovis AG to scale its own technology for the transformation of lignin – a byproduct of the pulp and paper industr...
Boehringer & Enara Bio Partner for Cancer Immunotherapy (2021-01-12)
> Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers > Latest in a series of strategic acquisitions and partnerships that strengthens Boehringer Ingelheim’s position in the cancer vaccine and T-cell engager spaces > Agreement...
€50m Launch of LSP Dementia Fund, Targets €150m (2021-01-12)
LSP, the leading European life sciences investor, today announces the launch of the LSP Dementia Fund, a fund dedicated to fight neurodegenerative diseases. The fund will be managed by Professor Philip Scheltens, a world-renowned dementia scientist and thought lead...
Novartis Licenses Tislelizumab from BeiGene, $650m Upfront (2021-01-11)
> Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and long-term growth > Novartis secures development and commercialization rights in North America, Europe, and Japan...
Affimed: up to $25m in Term Loans from SVB (2021-01-11)
€10 million available at closing and up to €15 million available upon achievement of certain milestones Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announce...
Boehringer & Google: Quantum Computing for Pharma R&D (2021-01-11)
> Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients > Scientists from both companies will be breaking new ground in the application of quantum computing to molecular dynamics simula...
Sanofi to Acquire Kymab for up to $1.45b (2021-01-11)
Continues to build on Sanofi’s leading presence in immunology aligned with strategy to pursue best-in-class treatments in defined areas Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on im...
Addex Therapeutics Completes $11.5m Capital Increase (2021-01-11)
Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the successful completion of the previously announced global offering of 6,900,000 sh...
Valo Health Raises $190m Series B Led by PSP Investments (2021-01-11)
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference Valo Health LLC (Valo), the technology company working to transform the drug discovery and development process and accelerate the creation of life-changing drugs...

» Show all News!

Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!

[LSG] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Germany, Austria and Switzerland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!

» Start here with the latest News!

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)